Aduhelm
Analysis: US FDA faces mounting criticism over Alzheimer’s drug approval
World
June 11, 2021
Analysis: US FDA faces mounting criticism over Alzheimer’s drug approval
In approving the first new Alzheimer’s drug in nearly 20 years, the US Food and Drug Administration is taking its…